Trastuzumab Biosimilar - Research Grade

Trastuzumab Biosimilar - Research Grade, Host: Humanized, IgG1 kappa
SKU
ICH4013-50MG
Packaging Unit
50mg
Manufacturer
Ichorbio

Availability: loading...
Price is loading...
Target: HER2.

Specificity: Detects human ErbB2. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Trastuzumab.

Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Background: Trastuzumab is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Trastuzumab is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary).

Concentration: 1.0 - 5.0 mg/ml.

Formulation: Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.

Purity: >95% by SDS-PAGE and HPLC.

Endotoxin: ≤ 0.75 EU/mg as determined by the LAL method.

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
More Information
SKU ICH4013-50MG
Manufacturer Ichorbio
Manufacturer SKU ICH4013-50MG
Package Unit 50mg
Quantity Unit STK
Reactivity Human
Clonality Monoclonal
Isotype IgG1 kappa
Host Humanized
Product information (PDF) Download
MSDS (PDF) Download